These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37989907)

  • 1. Lansoprazole inhibits the development of sessile serrated lesions by inducing G1 arrest via Skp2/p27 signaling pathway.
    Kawaguchi T; Okamoto K; Fujimoto S; Bando M; Wada H; Miyamoto H; Sato Y; Muguruma N; Horimoto K; Takayama T
    J Gastroenterol; 2024 Jan; 59(1):11-23. PubMed ID: 37989907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol inhibits development of colorectal adenoma via suppression of LEF1; comprehensive analysis with connectivity map.
    Wada H; Sato Y; Fujimoto S; Okamoto K; Bando M; Kawaguchi T; Miyamoto H; Muguruma N; Horimoto K; Matsuzawa Y; Mutoh M; Takayama T
    Cancer Sci; 2022 Dec; 113(12):4374-4384. PubMed ID: 36082704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite-instable colorectal cancers.
    van Toledo DE; Bleijenberg AG; Venema A; de Wit MJ; van Eeden S; Meijer GA; Carvalho B; Dekker E; Henneman P; IJspeert JE; van Noesel CJ
    J Pathol Clin Res; 2024 Mar; 10(2):e348. PubMed ID: 38380944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrogating colorectal cancer metastasis to liver: a search for clinically viable compounds and mechanistic insights in colorectal cancer Patient Derived Organoids.
    Cioce M; Fumagalli MR; Donzelli S; Goeman F; Canu V; Rutigliano D; Orlandi G; Sacconi A; Pulito C; Palcau AC; Fanciulli M; Morrone A; Diodoro MG; Caricato M; Crescenzi A; Verri M; Fazio VM; Zapperi S; Levrero M; Strano S; Grazi GL; La Porta C; Blandino G
    J Exp Clin Cancer Res; 2023 Jul; 42(1):170. PubMed ID: 37460938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5'tiRNA-Pro-TGG, a novel tRNA halve, promotes oncogenesis in sessile serrated lesions and serrated pathway of colorectal cancer.
    Wang XY; Zhou YJ; Chen HY; Chen JN; Chen SS; Chen HM; Li XB
    World J Gastrointest Oncol; 2023 Jun; 15(6):1005-1018. PubMed ID: 37389118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic diagnosis for colorectal sessile serrated lesions.
    Nishizawa T; Yoshida S; Toyoshima A; Yamada T; Sakaguchi Y; Irako T; Ebinuma H; Kanai T; Koike K; Toyoshima O
    World J Gastroenterol; 2021 Apr; 27(13):1321-1329. PubMed ID: 33833485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
    Wang ST; Ho HJ; Lin JT; Shieh JJ; Wu CY
    Cell Death Dis; 2017 Feb; 8(2):e2626. PubMed ID: 28230855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparate age and sex distribution of sessile serrated lesions and conventional adenomas in an outpatient colonoscopy population-implications for colorectal cancer screening?
    Lall V; Ismail AGM; Ayonrinde OT
    Int J Colorectal Dis; 2022 Jul; 37(7):1569-1579. PubMed ID: 35660947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the Japan narrow-band imaging expert team classification system for the diagnosis of sessile serrated lesion with dysplasia/carcinoma.
    Murakami T; Sakamoto N; Fukushima H; Shibuya T; Yao T; Nagahara A
    Surg Endosc; 2021 Aug; 35(8):4528-4538. PubMed ID: 32909209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions.
    Bettington M; Liu C; Gill A; Walker N; Leggett B; Whitehall V; Rosty C
    Histopathology; 2019 Jul; 75(1):81-87. PubMed ID: 30825335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted next-generation sequencing supports serrated epithelial change as an early precursor to inflammatory bowel disease-associated colorectal neoplasia.
    Singhi AD; Waters KM; Makhoul EP; Parian A; Lazarev MG; Proksell SS; Dueker JM; Schwartz MB; Wald AI; Nikiforova MN; Montgomery EA
    Hum Pathol; 2021 Jun; 112():9-19. PubMed ID: 33727167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological and molecular characterization of colorectal sessile serrated lesions with dysplasia.
    Cappello F; Angerilli V; Dal Santo L; Munari G; Sabbadin M; Lo Mele M; Pennelli G; Luchini C; Parente P; Lazzi S; Fassan M
    Pathol Res Pract; 2022 Dec; 240():154214. PubMed ID: 36395596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of EGFR and COX pathway inhibition in human colon organoids of serrated polyposis and other hereditary cancer syndromes.
    Kanth P; Hazel MW; Schell JC; Rutter J; Yao R; Mills AP; Delker DA
    Fam Cancer; 2024 Apr; ():. PubMed ID: 38609520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verification of the increase in concomitant dysplasia and cancer with the size of sessile serrated lesions.
    Ohki D; Tsuji Y; Hisada H; Nakagawa H; Mizutani S; Oshio K; Sato J; Kubota D; Cho R; Miura Y; Mizutani H; Sakaguchi Y; Takahashi Y; Yakabi S; Kakushima N; Yamamichi N; Ushiku T; Fujishiro M
    Endosc Int Open; 2024 Mar; 12(3):E448-E455. PubMed ID: 38550765
    [No Abstract]   [Full Text] [Related]  

  • 15. Sessile serrated lesions: Clinicopathological characteristics, endoscopic diagnosis, and management.
    Murakami T; Kurosawa T; Fukushima H; Shibuya T; Yao T; Nagahara A
    Dig Endosc; 2022 Sep; 34(6):1096-1109. PubMed ID: 35352394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic and endoscopic features of sessile serrated lesions and conventional adenomas: a large inpatient population-based study in China.
    Tan C; Qin G; Wang QQ; Zhou YC; Yao SK
    Front Oncol; 2024; 14():1337035. PubMed ID: 38638861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
    Kim JH; Hong JH; Choi YL; Lee JA; Seo MK; Lee MS; An SB; Sung MJ; Cho NY; Kim SS; Shin YK; Kim S; Kang GH
    J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic features with associated histological and molecular alterations in serrated polyps with dysplasia: Retrospective analysis of a tertiary case series.
    Trecca A; Borghini R; Medicina D; Del Sordo R; Mandelli G; Bella A; Galloro G; Fu KI; Villanacci V
    Dig Liver Dis; 2024 Apr; 56(4):687-694. PubMed ID: 37778895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide analysis of mRNA expression identified the involvement of trefoil factor 1 in the development of sessile serrated lesions.
    Sugai T; Osakabe M; Eizuka M; Tanaka Y; Yamada S; Yanagawa N; Matsumoto T; Suzuki H
    Pathol Res Pract; 2022 Aug; 236():153987. PubMed ID: 35749918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sessile serrated lesions with dysplasia: is it possible to nip them in the bud?
    Utsumi T; Yamada Y; Diaz-Meco MT; Moscat J; Nakanishi Y
    J Gastroenterol; 2023 Aug; 58(8):705-717. PubMed ID: 37219625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.